RTI Surgical Inc (NASDAQ:RTIX)

4.60
Delayed Data
As of Apr 20
 +0.025 / +0.55%
Today’s Change
3.85
Today|||52-Week Range
6.00
+12.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$307.5M

Company Description

RTI Surgical, Inc. is a global surgical implant company providing surgeons with biologic, metal and synthetic implants. It operates through the following business lines: Spine, Sports Medicine and Orthopedics, Surgical Specialties, Cardiothoracic, International, and Global Commercial. The Spine business line designs, manufactures, and distributes surgical implants, instruments, and biologics used in the treatment of conditions affecting the spine caused by degenerative conditions, deformities or traumatic injury. The Sports Medicine and Orthopedics business line deals with sports-related injuries that can be addressed with allograft implants. The Surgical Specialties business line markets and distributes implants for abdominal wall repair, and plastic and reconstructive surgery. The Cardiothoracic business line provides surgeons cardiothoracic cable, plating systems, and a biologic implant. The International business line markets and distributes products through a direct distribution organization and a network of independent distributors. The company was founded in 1997 and is headquartered in Alachua, FL.

Contact Information

RTI Surgical, Inc.
11621 Research Circle
Alachua Florida 32615
P:(386) 418-8888
Investor Relations:

Employees

Shareholders

Other institutional45.43%
Mutual fund holders21.18%
Individual stakeholders14.70%

Top Executives

Camille I. FarhatPresident, Chief Executive Officer & Director
John N. VarelaExecutive Vice President-Global Operations
Jonathon M. SingerCFO, Secretary & Chief Administrative Officer
Lennox K. ArchibaldMedical Director
Christopher R. GingrasDirector-Compliance